Geron Corp (GERN.OQ) Quote| Reuters.com
Edition:
United States

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

2.68USD
30 Jun 2016
Change (% chg)

$0.04 (+1.52%)
Prev Close
$2.64
Open
$2.62
Day's High
$2.72
Day's Low
$2.62
Volume
295,557
Avg. Vol
470,229
52-wk High
$5.25
52-wk Low
$2.31

GERN.OQ

Chart for GERN.OQ

About

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for... (more)

Overall

Beta: 2.82
Market Cap(Mil.): $419.66
Shares Outstanding(Mil.): 158.96
Dividend: --
Yield (%): --

Financials

  GERN.OQ Industry Sector
P/E (TTM): 737.43 41.10 35.71
EPS (TTM): -0.00 -- --
ROI: 0.40 -6.56 14.23
ROE: 0.40 -5.98 15.43

BRIEF-Geron Corp reports Q1 loss per share $0.06

* Geron corporation reports first quarter 2016 financial results and recent events

May 05 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.